Loading clinical trials...
Loading clinical trials...
The purpose of this study was to assess the safety and tolerability of ABBV-951 (Foslevodopa/Foscarbidopa) in participants with Parkinson's disease (PD). This was a single-arm study with preplanned a...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
AbbVie
NCT07310264 · Healthy Volunteers (HV), Parkinson's Disease (PD)
NCT07316296 · Parkinson's Disease (PD), Freezing of Gait, and more
NCT07417280 · Parkinson's Disease (PD), Essential Tremor, and more
NCT06107426 · Parkinson's Disease (PD)
NCT07533591 · Parkinson's Disease (PD)
University of Alabama at Birmingham - Main /ID# 207996
Birmingham, Alabama
Banner Sun Health Res Inst /ID# 208811
Sun City, Arizona
The Parkinson's & Movement Disorder Institute - Fountain Valley /ID# 216126
Fountain Valley, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions